Acetisal

Quick links to important sections

Acetisal

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acetisal

What is Acetisal? Overview and Classification

Property Description
Active Ingredient Acetylsalicylic Acid (ASA)
Form Tablets (Immediate-release, Enteric-coated), Suppositories
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID) and Platelet Aggregation Inhibitor
General Purpose Pain relief, fever reduction, clot prevention
Origin Synthetic compound (Salicylate derivative)

What is Acetisal and What is its Active Ingredient?

Acetisal is a medicinal product defined by its active component, Acetylsalicylic Acid (C₉H₈O₄), widely recognized as Aspirin. This substance is a synthetic compound derived from salicylic acid, placing it chemically within the Salicylate drug class. Acetisal is typically a single-ingredient product.

Acetisal's scientific profile is unique: it is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), but it also carries the critical classification of a Platelet Aggregation Inhibitor (an Antiplatelet agent). As such, the medicine is recognized for its ability to help relieve generalized discomfort and control fever. The compound's differentiating factor is its antiplatelet effect, a property that is highly regarded in pharmacological studies.


Acetisal's Pharmacological Class and General Purpose

Acetisal is defined by its ability to modulate the body's response to injury and illness. Its primary general purpose is to provide relief from mild-to-moderate physical discomfort, reduce fever, and manage inflammation.

The drug acts by suppressing the production of prostaglandins, the chemical messengers that mediate pain and fever. Furthermore, its separate function as a platelet aggregation inhibitor allows it to reduce the ability of blood components to form clots. This specialized antiplatelet action is intended to help maintain smoother blood flow and reduce clot formation risk, such as in typical scenarios requiring long-term antiplatelet therapy.


Available Forms and Preparation Types

The active ingredient, Acetylsalicylic Acid, is manufactured in various dosage forms for oral or rectal administration. The forms most commonly encountered are tablets and suppositories. Tablet forms include standard immediate-release types and specialized enteric-coated tablets. The enteric coating is a structural design intended to delay the dissolution of the active ingredient until it passes the stomach, optimizing absorption and minimizing potential local irritation.

Regulatory References

  1. National Library of Medicine (NLM) confirmed its status as a widely used NSAID

What side effects are possible with Acetisal?

Possible Side Effects and Safety Information for Acetisal

The safety profile of Acetisal (acetylsalicylic acid, ASA) primarily involves gastrointestinal effects, bleeding risks, and hypersensitivity reactions, as detailed in regulatory documents.


Documented Adverse Reactions

Common adverse reactions (occurring in 1% to 10% of users) typically include dyspepsia (indigestion) and an increased tendency toward bleeding.

Serious and Clinically Significant Adverse Reactions

The most severe risks documented by health authorities include:

  • Gastrointestinal Bleeding, Ulceration, and Perforation: This risk is dose- and duration-dependent and is increased in patients over 60, those with a history of ulcers, or concurrent use of blood thinners.
  • Reye's Syndrome: A rare but potentially fatal condition involving swelling in the liver and brain, linked to Acetisal use in children and teenagers recovering from a viral illness like the flu or chickenpox.
  • Hypersensitivity: Severe allergic reactions, including anaphylaxis (hives, facial swelling, shock), and aspirin-exacerbated respiratory disease (AERD) can occur.
  • Hemorrhage: Includes internal bleeding events, such as intracranial hemorrhage (bleeding in the brain).

High-Dose Effects: Tinnitus (ringing in the ears) and hearing loss are recognized signs of toxicity, often associated with higher salicylate concentrations.


Safety Restrictions and Contraindications

Acetisal is contraindicated for use in individuals with known allergy to salicylates or other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), active gastrointestinal ulcers, severe bleeding disorders, or severe liver or kidney disease. Due to the risk of Reye's Syndrome, it is generally not to be given to children or teenagers with viral symptoms.

Regulatory warnings advise against use in the last trimester of pregnancy due to risks to the fetus. Caution is advised when used concurrently with anticoagulants, other NSAIDs, or alcohol, which further increases the risk of serious bleeding events.

Overdose and Emergency Response

Overdose and when to seek help

Acetisal overdose is officially documented as salicylate toxicity and requires immediate medical intervention. Overdose manifestations are defined by the official prescribing information and typically begin with signs of salicylism, which include tinnitus (ringing in the ears), dizziness, hyperventilation (rapid breathing), nausea, vomiting, and confusion.

The documented risks include severe and life-threatening systemic and neurological outcomes. These can rapidly progress to profound Metabolic Acidosis, pulmonary edema, and serious complications such as seizures, cerebral edema, and respiratory failure. Immediate medical attention or contacting a Poison Control Center is required for any suspected overdose.

Management is strictly supportive, as no specific antidote is known according to regulatory documentation. Officially described emergency procedures include gastrointestinal decontamination, such as administering Activated Charcoal, and the critical use of Intravenous Sodium Bicarbonate to correct acid-base disturbances and enhance drug elimination. Hemodialysis is mandated for severe toxicity or when standard supportive treatments fail. Population-specific considerations note that children and patients with chronic exposure are particularly susceptible to rapid, severe deterioration.

Therapeutic Uses of Acetisal

What Acetisal Treats: Main Uses and Benefits

Acetisal (acetylsalicylic acid) is commonly used to provide supportive symptomatic relief across several acute domains, which may help patients cope more steadily with difficult episodes. It is relevant in contexts where short-term supportive management is needed to ease the overall symptom burden.


Management of Acute Pain and Discomfort

This therapeutic domain is relevant for easing distressing symptoms arising from physical discomfort. Acetisal is used for managing groups of symptoms that may appear suddenly, offering support that helps ease the overall symptom load during these acute periods. Symptom groups commonly addressed include headaches, muscle aches, and general body aches. It is commonly applied when pain symptoms create noticeable interference with daily functional stability.

“Acetisal is often used during phases when symptoms become more noticeable and supportive relief is needed.”


Symptomatic Relief of Fever and General Malaise

Acetisal is generally used across conditions presenting with acute episodes characterized by elevated body temperature (fever) and other discomforts accompanying viral or flu-like symptoms. It is applicable in conditions marked by periods of increased physiological stress, offering symptomatic relief in cases where symptoms cluster into patterns requiring supportive management. This use may assist with the temporary functional strain and contributes to easing the overall symptom load during symptomatic phases.

Quick Fact: Relief for Pain and Fever. Acetisal supports the management of symptoms related to physical discomfort and systemic imbalance, which may assist with functional stability during acute episodes.

Regulatory References

  1. NIH MedlinePlus Drug Information on Aspirin

Eligibility and Restrictions for Use

This section outlines the official eligibility and non-eligibility requirements for Acetisal (acetylsalicylic acid) based strictly on governmental regulatory documents.

Populations that Must Not Use Acetisal (Contraindications)

Official labeling mandates that Acetisal is contraindicated in several specific populations, prohibiting its use. These include:

  • Children and Adolescents: Must not be given to children and teenagers under 16 or 18 years of age (depending on the jurisdiction) who have or are recovering from viral illnesses such as flu or chicken pox, due to the established risk of Reye's Syndrome.
  • Hypersensitivity: Individuals with a history of allergy or hypersensitivity to Acetisal, other salicylates, or Nonsteroidal Anti-inflammatory Drugs (NSAIDs).
  • Bleeding Risk: Patients with an active peptic ulcer, a history of gastrointestinal bleeding related to prior NSAID use, a haemorrhagic diathesis, or other severe clotting disorders.
  • Organ Failure: Persons with severe hepatic impairment, severe renal insufficiency (e.g., GFR less than 10 mL/min), or severe, uncontrolled cardiac insufficiency.
  • Pregnancy: Contraindicated during the third trimester of pregnancy (doses greater than 100 mg/day) and generally avoided during breastfeeding.

Eligibility-Related Restrictions

Use is restricted or requires caution in the elderly, in patients with asthma induced by salicylates or NSAIDs, mild to moderate hepatic or renal impairment, or uncontrolled hypertension. The drug is also contraindicated for use with high-dose methotrexate (over 15 mg/week) due to interaction and toxicity risks.

What should I know about interactions with other medicines?

Acetisal Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Acetisal (Acetylsalicylic Acid, ASA) as defined by government regulatory documents, focusing strictly on required constraints and documented risks.


Formal Regulatory Prohibitions and Avoidance

Classification Interacting Agents
Contraindicated Combination Methotrexate (ge 15 mg/week) due to decreased renal clearance, increasing toxicity.
Combination to Avoid Uricosuric Agents (e.g., Probenecid) as Acetisal formally reverses their therapeutic effect.

Clinically Significant Interaction Patterns

Acetisal’s antiplatelet and NSAID properties contribute to pharmacodynamic reinforcement with several drug classes:

  • Increased Bleeding Risk: Co-administration with Oral Anticoagulants (e.g., Warfarin), other Antiplatelet Agents, SSRIs, and Systemic Corticosteroids is officially associated with an increased risk of haemorrhage or gastrointestinal damage.
  • Altered Drug Exposure: Acetisal can officially increase the plasma concentrations of certain co-administered drugs, including Digoxin, Lithium, and low-dose Methotrexate (<15 mg/week), by impairing their renal excretion.

Timing and Population Cautions

  • Timing: Taking Ibuprofen for pain relief may officially inhibit the antiplatelet effect of low-dose Acetisal, which may necessitate professional advice on appropriate timing separation.
  • Alcohol: Official regulatory warnings document an increased risk of severe stomach bleeding when Acetisal is combined with alcohol (ethanol).
  • Population Note: A specific caution is documented for Children and Teenagers with suspected Varicella or Influenza due to the association with Reye’s Syndrome.

Mechanism of Action

How Acetisal Works: Mechanism of Action

Acetisal's action is fundamentally defined by its unique interaction with the Cyclooxygenase (COX) enzyme system. It acts as an irreversible inhibitor of both COX-1 and COX-2 by permanently binding to and chemically modifying their active sites through acetylation. This molecular action suppresses the formation of key lipid mediators, such as prostaglandins, leading to the resetting of an elevated hypothalamic thermal set-point and the modulation of peripheral nociceptive signaling. The permanent inhibition of COX-1 is particularly consequential in anucleated platelets, which cannot synthesize new enzyme, causing a complete and lasting shutdown of Thromboxane A2 (TXA2) production. This results in a sustained reduction in the aggregation capacity of blood components.

Furthermore, the mechanism exhibits dose-dependent selectivity. While low concentrations are sufficient to achieve the primary action through COX-1 inhibition, higher concentrations also suppress Prostacyclin ( PGI2) by COX-2, creating a functional constraint that influences the balance between pro- and anti-aggregatory prostanoids within the vascular system.

Dosage and Administration Information

How to Use Acetisal: Official Administration Guidelines

The administration of Acetisal (acetylsalicylic acid) is governed by specific regulatory protocols that define its route, dosage, and timing, distinguishing between its use for acute symptoms and long-term therapy. The officially approved administration routes are Oral (for tablets and capsules) and Rectal (for suppositories).


Dosing and Frequency Patterns

Official labeling establishes distinct dosage patterns based on the purpose of use:

Usage Pattern Standard Labeled Dosing Frequency
Acute Symptomatic Relief (Pain/Fever) 325 mg to 1000 mg per dose; maximum 4000 mg daily. Every 4 to 6 hours, as needed.
Chronic Antiplatelet Regimen Maintenance dose 75 mg to 325 mg. Once daily.

Administration Context and Form Handling

Administration instructions define essential procedural steps for safe and effective intake. Acetisal oral doses are generally advised to be taken with or after food and with a full glass of water to support tolerance. For chronic, low-dose therapy, the regimen is typically long-term and ongoing. Conversely, use for minor acute symptoms should be limited to short-term periods, such as no more than 3 to 5 days for fever or pain, unless otherwise directed by a healthcare professional.

Specific forms, such as enteric-coated tablets or delayed-release capsules, must be swallowed whole and must not be crushed, split, or chewed. This instruction is critical for preserving the integrity of the product's release characteristics. Official guidance also mandates that administration to children under 12 years of age must occur only following medical advice.

Recent Clinical Evidence

Research evidence / Overview of studies for Acetisal


Evidence for Long-Term Clot Risk Reduction

Large-scale, placebo-controlled Randomized Controlled Trials (RCTs), along with Systematic Reviews and Meta-Analyses, studied Acetisal's antiplatelet properties. These studies examined long-term outcomes for adults who had an elevated incidence of a first major cardiovascular event, such as a heart attack or stroke. Researchers monitored composite endpoints related to the incidence of these events over observation periods spanning several years.

Studies tracked the frequency of nonfatal heart attack, nonfatal stroke, and outcomes related to mortality, and data show patterns related to vascular events that varied across different populations. The design and methodology of the evidence for this area are rated High. However, certainty remains low regarding the universal application of the findings. Long-term effects are not fully established outside of the specific study protocols, and the results apply only to the populations studied.


Evidence for Acute Symptom Relief (Pain and Fever)

Acetisal was studied for short-term symptom patterns related to acute conditions. The research base for this purpose includes historical Randomized Controlled Trials and Comparative Analgesic Studies. This use is supported by a research base that includes a long history of study data.

Studies explored changes in patient-reported outcomes describing perceived discomfort and also monitored physiological measures of Body Temperature. The evidence quality for this domain is generally considered High. However, a key limitation is the limited availability of contemporary, large-scale RCTs that specifically explore short-term symptom changes.


What Remains Uncertain About the Research

For the long-term antiplatelet use, evidence is limited in determining a uniform pattern for all adults, as the outcomes data show patterns related to an individual’s pre-existing incidence profile. Additionally, comparative evidence is lacking from contemporary, large-scale studies regarding symptomatic relief. Follow-up durations were limited for studies exploring acute symptom relief, and research is ongoing to explore findings across diverse patient groups.

Key Studies & References

  1. Aspirin Use to Prevent Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement (2022)
  2. Salicylic Acid (Aspirin) - StatPearls (General Indication and Use Monograph)

Frequently Asked Questions (FAQ)

Common questions about Acetisal (FAQ)

Q: How quickly does Acetisal start to work?

According to scientific literature and clinical data, when used for relieving symptoms such as pain or fever, the effects of Acetisal are typically observed to begin within about 30 minutes following administration of the oral form.

Q: What is the main difference between Acetisal and other common pain relievers?

Acetisal is chemically classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) but is uniquely distinguished by its antiplatelet property. Official product information highlights that this irreversible action helps reduce the ability of blood components to clot, a function generally not shared by many other common pain-relieving medicines.

Q: Can Acetisal be taken for a long time?

Regulatory labeling addresses two different contexts of use. When used for acute symptoms (like pain or fever), it is typically advised for only short-term use. However, when prescribed for its antiplatelet effect, the official guidance often describes it as a long-term and ongoing maintenance regimen, a management context that is typically supervised by a healthcare professional.

Q: What is the evidence that Acetisal helps with chronic pain?

Official indications primarily focus on the relief of acute pain conditions, such as headaches, toothaches, and symptoms related to inflammatory conditions like arthritis. Non-specific chronic pain is not generally described as a primary, specific indication within the regulatory product documentation.

Q: What should I do if a side effect seems mild but bothers me?

Patient information provided in regulatory-sourced documents instructs that if any side effects are bothersome, continue for a long time, or if you have questions about them, checking with a healthcare professional for guidance is generally recommended.

Q: Is it safe to drive after taking Acetisal?

Official warnings for some products containing Acetisal mention the potential for effects such as dizziness or drowsiness. These warnings advise that the medicine may impair a patient's ability to safely engage in potentially hazardous activities, such as driving a motor vehicle or operating machinery, if those effects occur.

Q: Can Acetisal be crushed or split?

Specific forms of the medicine, such as enteric-coated tablets or delayed-release capsules, are officially mandated to be swallowed whole. The regulatory reason for this instruction is that crushing or splitting these forms compromises the intended release characteristics of the medicine.

Q: What happens if I take Acetisal and it's expired?

Official instructions advise that any outdated or expired medicine should be properly disposed of, for instance, through a drug take-back program. Regulatory authorities generally advise against the use of any product past its labeled expiration date due to potential loss of potency or degradation.

Q: Does taking Acetisal with food change how it works?

Oral doses of Acetisal are generally advised to be taken with or after food, primarily to improve stomach tolerance and minimize local irritation. While food can affect the rate at which the ingredient is absorbed, the advice is mainly focused on mitigating gastrointestinal effects.

Q: How does Acetisal interact with blood pressure medication?

Official documentation often includes cautions regarding the co-administration of Acetisal with certain blood pressure-lowering medicines, such as diuretics or antihypertensives. This is because Acetisal may reduce the effectiveness of these medications, according to regulatory sources.

Q: Is Acetisal the same kind of medicine as aspirin?

Yes. The active ingredient in Acetisal is Acetylsalicylic Acid (ASA). This substance is scientifically known and commonly recognized in many regions by the established generic and trademarked name, Aspirin.

Q: Is it possible to become dependent on Acetisal?

Acetisal, when used as a single-ingredient product, is not classified as a controlled substance by regulatory bodies in most jurisdictions. Official labeling does not typically describe a potential for addiction or physical dependence on the medicine.

Q: Can older people use Acetisal?

Official warnings and precautions advise that caution is required in elderly patients. This is because this population may have an increased risk of gastrointestinal bleeding and other adverse effects, and a different dosage management may be considered by a healthcare professional.

Q: Is there a risk of stomach issues when taking Acetisal?

Yes, official safety information documents a risk of gastrointestinal effects. These risks range from common adverse reactions like indigestion (dyspepsia) to more serious risks such as GI bleeding, ulceration, and perforation.

Q: Do you need a prescription to get Acetisal?

Acetisal is available in several dosage strengths for common uses, such as pain relief, fever reduction, and low-dose antiplatelet therapy, as an Over-the-Counter (OTC) medicine in many jurisdictions, meaning a prescription is not required.

Q: What happens if I forget to take a dose of Acetisal?

Official patient instructions generally describe skipping the missed dose and simply resuming the regular schedule with the next scheduled dose. Regulatory guidance typically advises against taking a double dose to compensate for the missed one.

Q: Can Acetisal affect my sleep?

Adverse reactions reported in official documents, categorized under Nervous System or Psychiatric Disorders, include symptoms such as dizziness, nervousness, or trouble sleeping (insomnia), which are potential effects that may interfere with sleep patterns.

Q: Is Acetisal safe to use if I have kidney problems?

Regulatory documents state that Acetisal is contraindicated, meaning its use is prohibited, in individuals with severe renal insufficiency (very poor kidney function). Caution is generally advised and dosage modification may be necessary for those with mild to moderate kidney impairment.

Q: Are there any foods or drinks that should be avoided while using Acetisal?

Official regulatory warnings specifically document an increased risk of severe stomach bleeding when Acetisal is combined with alcohol (ethanol). Therefore, concurrent use of alcohol is generally advised against in the product safety information.

Q: Why do some people use Acetisal for purposes other than pain?

Official indications show that Acetisal has a key, approved use as a Platelet Aggregation Inhibitor. This function helps to reduce the risk of major cardiovascular events, such as heart attack or stroke, in specific populations, making it a treatment used beyond just pain and fever relief.

Q: Does Acetisal cause drowsiness?

Official documentation of adverse reactions includes reports of effects on the nervous system such as drowsiness, dullness, or lethargy. These are listed as potential side effects, often associated with higher concentrations of the medicine.

Q: How is Acetisal eliminated from the body?

According to the pharmacokinetics sections of official documents, the active ingredient is first metabolized (broken down) primarily in the liver. The resulting substances are then excreted mainly by the kidneys.

Q: Has Acetisal been studied in children?

Yes, Acetisal has been studied in children. However, official guidance includes a strong warning against its use in children and teenagers who are recovering from viral illnesses like the flu or chickenpox, due to the documented association with Reye's Syndrome.

Q: How long does Acetisal stay in the body?

While the active aspirin component is rapidly removed from the blood (in about 12 minutes), its active metabolite, salicylic acid, stays much longer. This active metabolite can have a half-life ranging from 3 to 15 hours, depending on the dose taken.

Q: Is Acetisal available in different strengths?

Yes, official dosage forms and strengths indicate that Acetisal is available in a variety of strengths. These include common doses such as 81 mg (low dose), 325 mg (regular strength), and 500 mg (extra strength), available across its various formulations.

Q: What if Acetisal does not seem to be working for me?

Patient labeling often provides general instructions that if the medicine does not provide relief, or if symptoms worsen or persist, the individual should seek the advice of a healthcare professional to determine the next steps.

Q: Are there generic versions of Acetisal available?

Yes, Acetisal's active ingredient, Acetylsalicylic Acid, is a widely available compound. Official regulatory listings confirm that numerous generic versions are available under different brand names and as generic drug products.

Q: What is the typical duration of treatment with Acetisal?

The required duration of treatment depends on the medication's purpose. For acute pain, it is used for short-term periods (e.g., typically a few days). For its antiplatelet effect, it is prescribed for long-term, ongoing daily use.

Q: Does Acetisal interact with common cold or flu medicines?

Regulatory warnings advise caution regarding co-administration with other medications that contain Non-Steroidal Anti-inflammatory Drugs (NSAIDs) or that may also increase bleeding risk. These components are often present in various over-the-counter cold and flu medicines.

Q: Is Acetisal a controlled substance?

No. When used as a single-ingredient medicine, Acetisal (Acetylsalicylic Acid) is not classified as a controlled substance under the U.S. Controlled Substances Act or similar international regulatory schedules.

Q: What does official guidance say about stopping Acetisal suddenly?

Official guidance documents, especially for patients on a long-term antiplatelet regimen, generally state that sudden discontinuation of the medicine is not recommended. Discontinuation is a change that is typically managed by a healthcare provider.

Q: Can Acetisal be used for headaches?

Yes, Acetisal is officially indicated for the relief of mild to moderate pain and is a common ingredient studied for this purpose. This includes relief for common conditions such as headache, according to regulatory documents.

Q: Is Acetisal a new or old medicine?

Acetisal (Acetylsalicylic Acid) is considered an old medicine. The compound's chemical predecessor has been in use for centuries, and the current compound has been in widespread use and study for well over 100 years.

Q: What is the official recommended purpose of Acetisal according to the FDA?

The official FDA-approved purposes include: relief of pain, fever, and inflammation, and reducing the risk of major cardiovascular events (such as heart attack or stroke) in specific populations determined to be at risk.

Q: Are there different formulations of Acetisal (e.g., tablet, liquid)?

Yes, the active ingredient is manufactured in several dosage forms. These include standard immediate-release tablets, enteric-coated tablets, chewable tablets, and suppositories, allowing for different administration routes.

How should Acetisal be stored and disposed of?

How to Store and Dispose of Acetisal?

The official storage and disposal requirements for Acetisal (Acetylsalicylic Acid) are mandatory to ensure stability and public safety.


Required Storage Conditions

Acetisal must be stored at controlled room temperature, typically between 15 C and 30 C (59 F and 86 F), and excessive heat must be avoided. The medicine must be kept in its original container with the lid tightly closed to protect it from moisture, as this can cause the product to degrade. Furthermore, the label requires that Acetisal be stored out of the sight and reach of children to prevent accidental ingestion.


Official Disposal Instructions

Unused or expired Acetisal should be disposed of via an authorized drug take-back program or collection site. If a take-back program is unavailable, official guidelines permit mixing the medicine with an undesirable substance, sealing it in a container, and placing it in household trash. Do not flush Acetisal down the toilet or pour it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Acetisal found in:

A-Z Index: